Announcements Trials
Browse Landscape

Status

Recruiting 164Active not recruiting 91Completed 66Terminated 27Not yet recruiting 25Enrolling by invitation 4Suspended 3Available 3Withdrawn 2

Sponsor Class

INDUSTRY 3

Study Type

Expanded_access 3

Sponsor

Cancer Type

Lymphoid 3Sarcoma 1Plasma cell 1Myeloid 1Gynecologic 1

Conditions

Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Sarcoma 5Recurrence 4Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Ovarian Neoplasms 4Neuroblastoma 4Multiple Myeloma 4Breast Neoplasms 4Melanoma 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Myeloid, Acute 3Hematologic Neoplasms 3Head and Neck Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Primary Myelofibrosis 2Osteosarcoma 2Non-Muscle Invasive Bladder Neoplasms 2Neuroectodermal Tumors, Primitive 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lymphoma 2Insulinoma 2Hypoglycemia 2Hyperinsulinism 2

Interventions

selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Available × Lymphoma, Large B-Cell, Diffuse × 1 year × Clear all
NCT07215832 2026-03-02

KEAP

Karyopharm Therapeutics Inc

Available
GynecologicLymphoidMyeloidPlasma cellSarcoma

Multiple Myeloma, Sarcoma, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral, Endometrial Neoplasms, Primary Myelofibrosis

NCT05619367 2025-12-23

A Compassionate Use (CU) Program of Odronextamab

Regeneron Pharmaceuticals

Available
Lymphoid

Lymphoma, Follicular, Recurrence, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT04400591 2025-12-11

Nonconforming Lisocabtagene Maraleucel Expanded Access Protocol

Juno Therapeutics, a Subsidiary of Celgene

Available
Lymphoid

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon âš¡